Chlamydia pneumoniae-induced pathological signaling in the vasculature

FEMS Immunology and Medical Microbiology

Volumn 55, Issue 2, 2009, Pages 131-139

  Kern, Jan Marco ^a   Maass, Viola ^a   Maass, Matthias ^a,b  

^a St Johanns Spital   (Austria)

^b University Hospital Salzburg   (Austria)

Author keywords

Angiogenesis; Atherosclerosis; Chlamydia pneumoniae; Inflammation; Signal transduction

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ATHEROSCLEROSIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 60049085128     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00514.x     Document Type: Conference Paper

References (66)

1. Anderson JL (2005) Infection, antibiotics, and atherothrombosis - end of the road or new beginnings? N Engl J Med 352 : 1706 1709.
2. Anderson JL Muhlestein JB (2004) Antibiotic trials for coronary artery disease. Tex Heart I J 31 : 33 38.
3. Bavendiek U, Libby P, Kilbride M, Reynolds R, Mackman N Schönbeck U (2002) Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem 277 : 25032 25039.
4. Blessing E, Campbell LA, Rosenfeld ME, Chesebro B Kuo CC (2005) A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae. J Antimicrob Chemoth 55 : 1037 1040.
5. Boman J Hammerschlag MR (2002) Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 15 : 1 20.
6. Brat DJ, Bellail AC Van Meir EG (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncology 7 : 122 133.
7. Campbell LA Kuo CC (2004) Chlamydia pneumoniae - an infectious risk factor for atherosclerosis. Nat Rev 2 : 23 32.
8. Campbell LA, Blessing E, Rosenfeld M, Lin T Kuo CC (2000) Mouse models of C. pneumoniae infection and atherosclerosis. J Infect Dis 181 : 508 513.
9. Coombes BK Mahony JB (1999) Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via endothelial cell-derived soluble factor(s). Infect Immun 67 : 2909 2915.
10. Coombes BK, Chiu B, Fong IW Mahony JB (2002) Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis. J Infect Med 185 : 1621 1630.
11. Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H Miethke T (2004) Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur J Immunol 34 : 2874 2884.
12. Dechend R, Maass M, Gieffers J, Dietz R, Schneidereit C, Lentz A Gulba DC (1999) Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated atherosclerosis. Circulation 100 : 1369 1373.
13. Dechend R, Gieffers J, Dietz R, Joerres A, Rupp J, Luft FC Maass M (2003) Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation. Circulation 108 : 261 265.
14. de Graaf R, Kloppenburg G, Kitslaar PJ, Bruggeman CA Stassen F (2006) Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect 8 : 1859 1865.
15. Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, Ying S Häcker G (2004) Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 200 : 905 916.
16. Fong IW, Chiu B, Viira E, Fong MW, Jang D Mahoney JB (1997) Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 35 : 48 52.
17. Fryer RH, Schwobe EP, Woods ML Rodgers GM (1997) Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Invest Med 45 : 168 174.
18. Gaydos CA (2000) Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 181 : 473 478.
19. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and aortic smooth muscle cells. Infect Immun 64 : 1614 1620.
20. Gieffers J, Füllgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, Solbach W Maass M (2001) Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103 : 351 356.
21. Gieffers J, Rupp J, Gebert A, Solbach W Klinger M (2004a) First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae. Antimicrob Agents Ch 48 : 1402 1405.
22. Gieffers J, van Zandbergen G, Rupp J, Sayk F, Krüger S, Ehlers S, Solbach W Maass M (2004b) Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur Respr J 23 : 506 510.
23. Girardin SE, Boneca IG, Carneiro LA et al 2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300 : 1584 1587.
24. Godzik KL, O'Brien ER, Wang AK Kuo CC (1995) In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 33 : 2411 2414.
25. Grayston JT (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181 : 402 410.
26. Grayston JT, Kronmal RA, Jackson LA, Parisi AF, Muhlestein JB Cohen JD (2005) Azithromycin for the secondary prevention of coronary events. N Engl J Med 352 : 1637 1645.
27. Haralambieva IH, Iankov ID, Ivanova PV, Mitev V Mitov IG (2004) Chlamydophila pneumoniae induces p44/p42 mitogen-activated protein kinase activation in human fibroblasts through Toll-like receptor 4. J Med Microbiol 53 : 1187 1193.
28. Hirono S, Dibrov E, Hurtado C, Kostenuk A, Ducas R Pierce GN (2003) Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. Circ Res 93 : 710 728.
29. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP Byrne GI (1999) Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 180 : 780 790.
30. Kalayoglu MV, Indrawati, Morrison RP, Morrison SG, Yuan Y Byrne GI (2000) Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis 181 : 483 489.
31. Khachigian LM, Lindner V, Williams AJ Collins T (1996) Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271 : 1427 1431.
32. Kis Z, Treso B, Burian K, Endresz V, Pallinger E, Nagy A, Toth A, Takacs M, Falus A Gonczol E (2008) Expression of bacterial genes and induction of INF-gamma in human myeloid dendritic cells during persistent infection with Chlamydophila pneumoniae. FEMS Immunol Med Mic 52 : 324 334.
33. Kol A, Sukhova GK, Lichtman AH Libby P (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor alpha and matrix metalloproteinase expression. Circulation 98 : 300 307.
34. Krüll M, Maass M, Suttorp N Rupp J (2005) Chlamydophila pneumoniae. Mechanisms of target cell infection and activation. Thromb Haemostasis 94 : 319 326.
35. Kuo CC, Gown AM, Benditt EP Grayston JT (1993a) Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Atheroscler Thromb 13 : 1501 1504.
36. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL Grayston JT (1993b) Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167 : 841 849.
37. Kutlin A, Flegg C, Stenzel D, Reznik T, Roblin PM, Mathews S, Timms P Hammerschlag MR (2001) Ultrastructural study of Chlamydia pneumoniae in a continous-infection model. J Clin Microbiol 39 : 3721 3723.
38. Libby P (2006) Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 83 : 456 460.
39. Libby P, Ridker PM Maseri A (2002) Inflammation and atherosclerosis. Circulation 105 : 1135 1143.
40. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V Saikku P (1993) Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 87 : 1130 1134.
41. Maass M, Bartels C, Engel PM, Mamat U Sievers HH (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 187 : 103 106.
42. Maass M, John J, Gieffers J, Dahlhoff K, Katus HA Solbach W (2000) Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction. J Infect Dis 181 : 449 451.
43. Mathews S, George C, Flegg C, Stenzel D Timms P (2001) Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae. Microb Pathogenesis 30 : 337 345.
44. Miller SA, Selzman CH, Shames BD, Barton HA, Johnson SM Harken AH (2000) Chlamydia pneumoniae activates nuclear factor kappa B and activator protein 1 in human vascular smooth muscle and induces cellular proliferation. J Surg Res 90 : 76 81.
45. Molestina RE, Klein JB, Miller RD, Pierce WH, Ramirez JA Summersgill JT (2002) Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 70 : 2976 2981.
46. Muhlestein JB (2000) Chlamydia pneumoniae-induced atherosclerosis in a rabbit model. J Infect Dis 181 : 505 507.
47. Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD Pearson RR (2000) Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation 102 : 1755 1760.
48. Netea MG, Selzmann CH Kullberg BJ (2000) Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 30 : 541 549.
49. Netea MG, Kullberg BJ, Galama JM, Stalenhoef AF, Dinarello CA Van der Meer JW (2002) Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways. Eur J Immunol 32 : 1188 1195.
50. O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L Gupta S (2003) Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290 : 1459 1466.
51. Opitz B, Förster S, Hocke AC, Maass M, Schmeck B, Hippenstiel S, Suttorp N Krüll M (2005) Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res 96 : 319 326 J, Wilson DP, Myers G, Timms P Bavoil PM (2007) Type III secretion à la Chlamydia. Trends Microbiol 15 : 241 251.
52. Pockley AG (2002) Heat shock proteins, inflammation, and cardiovascular disease. Circulation 105 : 1012 1017.
53. Prebeck S, Kirschning C, Dürr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H Miethke T (2001) Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunnol 167 : 3316 3323.
54. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340 : 115 126.
55. Rossmann A, Henderson B, Heidecker B, Seiler R, Fraedrich G, Singh M, Parson W, Keller M, Grubeck-Loebenstein B Wick G (2008) T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp Gerontol 43 : 229 237.
56. Rupp J, Berger M, Reiling N, Gieffers J, Lindschau C, Haller H, Dalhoff K Maass M (2004a) Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression. Biochem Biophys Res Commun 320 : 738 744.
57. Rupp J, Goepel W, Kramme E, Jahn J, Solbach W Maass M (2004b) CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes. Genes Immun 5 : 435 438.
58. Rupp J, Hellwig-Bürgel T, Wobbe V, Seitzer U, Brandt E Maass M (2005a) Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. P Natl Acad Sci USA 102 : 3447 3452 J, Koch M, van Zandvergen G, Solbach W, Brandt E Maass M (2005b) Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model. FEMS Microbiol Lett 242 : 203 208.
59. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Mäkelä PH, Huttunen JK Valtonen V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2 : 983 986.
60. Sasu S, LaVerda D, Qureshi N, Golenbock DT Beasley D (2001) Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p42/44 mitogene-activated protein kinase activation. Circ Res 89 : 244 250.
61. Shor A, Kuo CC Patton DL (1992) Detection of Chlamydia pneumoniae in the coronary artery atheroma plaque. S Afr Med J 82 : 158 161.
62. Summersgill JT, Molestina RE, Miller RD Ramirez JA (2000) Interactions of Chlamydia pneumoniae with human endothelial cells. J Infect Dis 181 : 479 482.
63. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiß NS Daling JR (1992) Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268 : 68 72.
64. Xiao Q, Mandal K, Schett G, Mayr M, Wick G, Oberhollenzer F, Willeit J, Kiechl S Xu Q (2005) Association of serum-soluble heat shock protein 60 with carotid atherosclerosis. Stroke 36 : 2571 2576.
65. Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, Willeit J, Kiechl S Wick G (2000) Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102 : 14 20.
66. van Zandbergen G, Gieffers J, Kothe H et al 2004) Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis. J Immunol 172 : 1768 1776.